COVID-19: 2 More Mucosal Skin Ulcer Cases Reported in Male Teens

Irish dermatologists are reporting two more cases of a rare skin ulcer known as reactive infectious mucocutaneous eruption (RIME) in teenage males who were infected with COVID-19. A similar case in an adolescent, also with ulcers affecting the mouth and penis, was reported earlier this year in the United States.

Dr Stephanie Bowe

“Our cases show that a swab for COVID-19 can be added to the list of investigations for mucosal and cutaneous rashes in children and probably adults,” said dermatologist Stephanie Bowe, MD, of South Infirmary-Victoria University Hospital in Cork, Ireland, in an interview. “Our patients seemed to improve with IV steroids, but there is not enough data to recommend them to all patients or for use in the different cutaneous presentations associated with COVID-19.”

The new case reports were presented at the 2021 meeting of the World Congress of Pediatric Dermatology and published online September 20 in Pediatric Dermatology.

Researchers have noted that skin disorders linked to COVID-19 infection are different than those in adults. In children, the conditions include morbilliform rash, pernio-like acral lesions, urticaria, macular erythema, vesicular eruption, papulosquamous eruption, and retiform purpura. “The pathogenesis of each is not fully understood but likely related to the inflammatory response to COVID-19 and the various pathways within the body, which become activated,” Bowe said.

The first patient, a 17-year-old boy, presented at clinic 6 days after he’d been confirmed to be infected with COVID-19 and 8 days after developing fever and cough. “He had a two-day history of conjunctivitis and ulceration of his oral mucosa, erythematous circumferential erosions of the glans penis with no other cutaneous findings,” the authors write in the report.

The boy “was distressed and embarrassed about his genital ulceration and also found eating very painful due to his oral ulceration,” Bowe said.

The second patient, a 14-year-old boy, was hospitalized 7 days after a positive COVID-19 test and 9 days after developing cough and fever. “He had a five-day history of ulceration of the oral mucosa with mild conjunctivitis,” the authors wrote. “Ulceration of the glans penis developed on day 2 of admission.”

The 14-year-old was sicker than the 17-year-old boy, Bowe said. “He was unable to tolerate an oral diet for several days and had exquisite pain and vomiting with his coughing fits.”

This patient had a history of recurrent herpes labialis, but it’s unclear whether herpes simplex virus (HSV) played a role in the COVID-19-related case. “There is a possibility that the patient was more susceptible to viral cutaneous reactions during COVID-19 infection, but we didn’t have any definite history of HSV infection at the time of mucositis,” Bowe said. “We also didn’t have any swabs positive for HSV even though several were done at the time.”

Both patients received IV steroids — hydrocortisone at 100 mg 3 times daily for 3 days. This treatment was used “because of deterioration in symptoms and COVID-19 infection,” Bowe said. “IV steroids were used for respiratory symptoms of COVID-19, so we felt these cutaneous symptoms may have also been caused by an inflammatory response and might benefit from steroids. There was very little literature about this specific situation, though.”

She added that IV steroids wouldn’t be appropriate for most pediatric patients, and noted that “their use is controversial in the literature for erythema multiforme and RIME.”

In addition, the patients received betamethasone valerate 0.1% ointment once daily, hydrocortisone 2.5 mg buccal tablets 4 times daily, analgesia with acetaminophen and ibuprofen, and IV hydration. The first patient also received prednisolone 1% eye drops, while the second patient was given lidocaine hydrochloride mouthwash and total parenteral nutrition for 5 days.

The patients were discharged after 4 and 14 days, respectively.

Dermatologists in Massachusetts reported a similar case earlier this year in a 17-year-old boy who was positive for COVID-19 and presented with “shallow erosions of the vermilion lips and hard palate, circumferential erythematous erosions of the periurethral glans penis, and 5 small vesicles on the trunk and upper extremities.”

The patient received betamethasone valerate 0.1% ointment for the lips and penis, intraoral dexamethasone solution, viscous lidocaine, acetaminophen, and ibuprofen. He also received oral prednisone at approximately 1 mg/kg daily for 4 consecutive days after worsening oral pain. A recurrence of oral pain 3 months later was resolved with a higher and longer treatment with oral prednisone.

Dermatologists have also reported at least cases cases of erythema multiforme lesions of the mucosa in adults with COVID-19. One case was reported in Iran, and the other in France.

The authors report no study funding and have disclosed no relevant financial relationships.

Pediatr Dermatol. Published online September 20, 2021. Full text

World Congress of Pediatric Dermatology: Abstract SP06. To be presented September 23, 2021.

Randy Dotinga is a freelance journalist who covers medicine and health.

For more news, follow Medscape on Facebook, Twitter, Instagram, YouTube, and LinkedIn

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Advanced Parkinson's Symptoms Improved With Focused Ultrasound thumbnail

Advanced Parkinson’s Symptoms Improved With Focused Ultrasound

Neurology > Parkinson's Disease — Pivotal trial shows 3-month improvement, but longer study is needed by Judy George, Deputy Managing Editor, MedPage Today February 22, 2023 Unilateral focused ultrasound ablation targeted to the globus pallidus internus led to a higher percentage of Parkinson's disease patients with improved motor function or reduced dyskinesia compared with sham
Read More
Walmart Health announces partnership with Epic thumbnail

Walmart Health announces partnership with Epic

Walmart announced this week that it would begin using Epic's electronic health record in its health centers, starting in Florida in early 2022. Eventually, all of Walmart's health and wellness lines of business will be supported by the Epic platform as it's rolled out.   "The Epic system complements our omnichannel health care offerings – letting customers…
Read More
U.S. debt default could endanger provider payments thumbnail

U.S. debt default could endanger provider payments

Skip to main content Hospitals and health systems hope for a resolution to the federal government’s debt ceiling standoff, warning that a failure to reach an agreement could have a catastrophic impact on provider payments. Republicans and Democrats continue to haggle over a deal to raise the $31.4 trillion national debt limit and keep the
Read More
Pharyngolaryngeal reflux syndrome: a clinical picture [podcast] thumbnail

Pharyngolaryngeal reflux syndrome: a clinical picture [podcast]

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed Quer acessar esse e outros conteúdos na íntegra? Cadastrar GrátisJá tem cadastro? Faça seu login Faça seu login ou cadastre-se gratuitamente para ter acesso ilimitado a todos os…
Read More
Altera Digital Health to deliver Provation's anaesthesia solutions to Te Whata Ora Waikato thumbnail

Altera Digital Health to deliver Provation’s anaesthesia solutions to Te Whata Ora Waikato

Te Whata Ora Waikato, formerly the Waikato District Health Board, has tapped Altera Digital Health to implement a full suite of cloud-based anaesthesia information management tools from healthcare technology provider Provation to replace the old paper-based processes in its health services. WHAT IT'S ABOUT Based on a media release, Altera will be delivering the Provation…
Read More
Index Of News
Total
0
Share